Status:
UNKNOWN
Efficacy of Extracorporeal Shock Wave Therapy on Carpal Tunnel Syndrome Post Mastectomy Lymphedema
Lead Sponsor:
Cairo University
Conditions:
Carpal Tunnel Syndrome
Eligibility:
FEMALE
40-60 years
Phase:
NA
Brief Summary
Sixty eight female patients who had symptoms of carpal tunnel syndromesuch as wrist pain or numbness and paraesthesia and had lymphedema of an upper extremity.Their ages will be ranged from 40 to 60 y...
Detailed Description
In this study the patients will be randomly assigned into two equal groups(34 patients for each group)Group A (experimental group):This group includes 34female patients who will receive extra corporea...
Eligibility Criteria
Inclusion
- All participants could be considered and enrolled if they conformed to the diagnosis of CTS, with clinical symptoms for at least 3 months.
- The clinical symptoms and signs for the diagnosis of CTS were as follows:
- Paresthesias and painful swelling with weakness of the affected hand, exacerbated while sleeping or by repetitive use of the wrist, which would be relieved by shaking the hand with postural change.
- Sensory loss with numbness in the regions of the hand innervated by the median nerve;
- Impaired motor function with atrophy of the median nerve-innervated thenar muscles.
- Positive Tinel's sign.
- The subject selection will be according to the following criteria:
- Female patient their age range between 40-60 years.
- Symptoms of CTS as pain, tingling sensation for at least 3 months.
- Unilateral or bilateral Lymphedema following mastectomy
- All patients enrolled to the study will have their informed consent.
Exclusion
- The potential participants will be excluded if they meet one of the following criteria:
- Local infections at the hand level.
- Patients with prior medical histories of cardiac arrhythmias.
- Patient with venous thrombosis.
- Areas of skin with lesions and impaired sensation
- Other diseases that cause significant swelling.
- During pregnancy and breastfeeding.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT06131515
Start Date
November 1 2023
End Date
December 1 2023
Last Update
November 15 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Khadra Mohamed Ali
Cairo, Egypt
2
Shahira Sami
Cairo, Egypt